Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NorthWest Healthcare Properties Real Estate Invest 10 Convert Sub Debentures 31 March 2025 T.NWH.DB.G

Alternate Symbol(s):  NWHUF | T.NWH.UN | T.NWH.DB.H | T.NWH.DB.I

Northwest Healthcare Properties Real Estate Investment Trust is an open-ended real estate investment trust. The Company is the owner and operator of healthcare real estate infrastructure in North America, Brazil, Europe and Australasia. The principal business of the Company is to invest in healthcare real estate globally. It focuses on the cure segment of healthcare real estate, such as hospitals, medical office buildings, and clinics. Its asset class segmentation includes hospitals and healthcare facilities; medical office buildings; and life sciences, research, and education. It provides investors with access to a portfolio of international healthcare real estate infrastructure of interests in a diversified portfolio of about 196 income-producing properties located throughout major markets in North America, Brazil, Europe and Australasia. Its portfolio of medical office buildings, clinics, and hospitals is characterized by long-term indexed leases and stable occupancies.


TSX:NWH.DB.G - Post by User

Post by incomedreamer11on Oct 10, 2023 9:38am
310 Views
Post# 35676816

Scotia comments

Scotia comments

Laying Out Cards on the Table

OUR TAKE: Mixed. We initiated coverage on NWH in first week of Sep’23 – see our detailed 59-page report (link). In a couple of weeks, we were restricted as NWH provided an update on the strategic review process. We are now off-restriction, and resuming coverage with a target of $6.50 (-$1.50) and unchanged SP rating. A lot has happened in the last few weeks – Exhibit 1 where we summarize all the recent developments (distribution cut, strategic review, NWVP interest, etc). Our NAVPU is reduced to $8.50 (-$0.75) and our 2024E AFFOPU is reduced by 33% (Exhibit 11), and in line with soft guidance from the management. Current distribution yield (post 55% cut) = 7.0% @82% ‘24E payout ratio (Exhibit 13).

We think NWH should appeal to “Value” investors as risk-reward profile has improved. NWH unit price is down ~25% since beginning of Sep’23, and we are almost running out of bad news now (Exhibits 4, 5 & 6). We did a scenario analysis (Exhibit 3) and think floor price could be $4.50 to $4.75 (Scenario 1) while bull-case could imply $8.00 to $9.00 (Scenario 4). See below for five different scenarios:

Scenario 1: Bear-case. NWH is not successful with dispositions while interest rate expenses increase further and stay elevated for full 2024. Our NAVPU decreases to $5.50 (based on 7.55% cap rate) and 2024 AFFOPU reduces by 7.5% from Scotia estimate. Exhibit 3 for details. Assuming 15% discount to bear-case NAV, $4.50 to $4.75 could be the floor in the near-term. At this floor price, AFFO yield spread to 10-yr GoC will be 575bp (vs historical average of 590bp – Exhibit 15).

Scenario 2: Reasonable scenario. US disposition + UK JV + Rate cuts in 2024, and we assume dispositions at 20% discount to our base portfolio value – this could be most likely event. In that case, NAVPU is $7.25 and 2024E AFFOPU reduces to $0.416. Here, pro forma leverage goes down to 49% (from 58% Debt/Assets).

Scenario 3: Limited success with dispositions. UK JV formation but interest rates remain elevated for full 2024. Leverage remains elevated and NAVPU at $7.75 and AFFOPU at $0.422. Here, pro forma leverage goes down to 53% (from 58% Debt/Assets).

Scenario 4: Bull-case scenario. In case of an M&A event, a bid could come in at $8.00+ range. This could still offer investors ~55% premium to recent price (vs ~20% on an average in past M&A’s) and yet 6% discount to consensus NAV (vs ~20% on an average in past M&A’s). List of past M&A’s (Exhibit 39).

Scenario 5: Base-case (Exhibit 2). We assume no dispositions in 2024. Our NAV cap rate of 6.6% vs IFRS cap rate of 5.6%, and assumes 7.1% for Americas, 6.25% for Europe and 5.75% for Australasia. Our NAVPU is $8.50 and leverage remains elevated for full next year.


<< Previous
Bullboard Posts
Next >>